ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 66.00
-0.10 (-0.15%)
Dec 31, 2025, 2:59 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.04 billion as of December 31, 2025. Its market cap has increased by 145.81% in one year.
Market Cap
4.04B
Enterprise Value
3.60B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.00
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 4.04B, an increase of 192.76%. That is a compound annual growth rate of 27.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |